Brief: Epigenomics board recommends acceptance of voluntary public takeover offer
14/06/2017 07:55
June 14 (Reuters) - EPIGENOMICS AG ECXn.DE :
* EPIGENOMICS AG: EXECUTIVE BOARD AND SUPERVISORY BOARD
RECOMMEND ACCEPTANCE OF THE VOLUNTARY PUBLIC TAKEOVER OFFER
* EXECUTIVE BOARD AND SUPERVISORY BOARD OF EPIGENOMICS AG
HAVE EVALUATED VOLUNTARY PUBLIC TAKEOVER OFFER OF SUMMIT HERO
HOLDING GMBH ("BIDDER")
* EXECUTIVE BOARD AND SUPERVISORY BOARD OF EPIGENOMICS AG
WELCOME TAKEOVER OFFER AND RECOMMEND TO SHAREHOLDERS TO ACCEPT
IT
* FROM PERSPECTIVE OF EXECUTIVE BOARD AND SUPERVISORY BOARD,
OFFER PRICE IS FAIR AND REASONABLE
Source text for Eikon: ID:nEQBSf0da
Further company coverage: ECXn.DE
(Gdynia Newsroom)
((gdynia.newsroom@thomsonreuters.com; +48 58 722 0920;))
Recent news on Epigenomics AG
See all newsU.S. FDA advisers back approval for Guardant's blood-based cancer test (updated)
U.S. FDA advisers back approval for Guardant's cancer test
Brief: Epigenomics Says Closing Of Agreement On The Acquisition Of Almost All Assets And Adjustment Of Guidance For 2023
Brief: Epigenomics AG Says It Entered Into Agreement On The Acquisition Of Almost All Assets With New Day Diagnostics LLC
Brief: Epigenomics Says Chief Scientific Officer Andrew Lukowiak Resigns